Last reviewed · How we verify
NCT06631911: EAET for PPS
Emotional Awareness and Expression Therapy for Patients With Persistent Physical Symptoms in Routine Psychiatric Care: A Pilot Study
NA trial testing Emotional Awareness and Expression Therapy (EAET) in Persistent Physical Symptoms (PPS) in 50 participants. Not yet recruiting.
31 December 2025
Quick facts
| Lead sponsor | Daniel Maroti |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 November 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
Drugs / interventions tested
- Emotional Awareness and Expression Therapy (EAET)
Conditions studied
- Persistent Physical Symptoms (PPS) — all drugs for Persistent Physical Symptoms (PPS) →
- Functional Somatic Disorder — all drugs for Functional Somatic Disorder →
- Functional Somatic Syndromes — all drugs for Functional Somatic Syndromes →
- Somatic Symptom Disorder (DSM-5) — all drugs for Somatic Symptom Disorder (DSM-5) →
Sponsor
Daniel Maroti
Who can join
18 and older, any sex, with Persistent Physical Symptoms (PPS) or Functional Somatic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Emotional Awareness and Expression Therapy (EAET) has emerged as a promising approach for addressing persistent physical symptoms (PPS). Investigating EAET within the context of routine psychiatric care is crucial for several reasons: Many patients with PPS experience significant distress and functional impairment, yet traditional medical treatments often fail to provide adequate relief. Integrating EAET into routine care could offer a valuable therapeutic option for this population. Preliminary studies suggest that EAET can lead to significant reductions in pain and other somatic symptoms. Investigating its effectiveness in routine care settings could enhance treatment outcomes for patients who have not responded to conventional therapies. There is often a disconnect between mental health and physical health treatment in routine care. Investigating EAET can help bridge this gap, fostering collaboration between mental health professionals and primary care providers to address the complexities of patients\' health issues.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06631911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Emotional Awareness and Expression Therapy (EAET)
Trials testing the same drug.
- NCT07282392 — Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET) · NA · recruiting
- NCT05837650 — Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment · NA · completed
Other Daniel Maroti trials
Trials by the same sponsor.
- NCT06682104 — ISTDP for Patients with Treatment Resistance PPS · NA · not yet recruiting
- NCT06631963 — Telehealth Group-based Emotional Awareness and Expression Therapy for Patients With Persistent Physical Symptoms: A Pilo · NA · not yet recruiting
- NCT06301360 — Internet Based Emotional Awareness and Expression Therapy for Functional Somatic Disorder With and Without Therapist Sup · NA · unknown
- NCT06149182 — Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Pa · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06631911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Daniel Maroti
- Last refreshed: 8 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06631911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing